13F HOLDINGS REPORT
Foresite Capital Management V, LLC
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0001104659-25-013930
Total Value
$120.2M
Positions
6
Other Managers
0
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Alumis Inc | ALMS | 5,779,348 | $45.4M | 37.79% |
| 2 | Hims & Hers Health, Inc. | HIMS | 939,860 | $22.7M | 18.91% |
| 3 | CG Oncology, Inc. | CGON | 692,550 | $19.9M | 16.53% |
| 4 | Disc Medicine, Inc. | IRON | 299,069 | $19.0M | 15.78% |
| 5 | Cullinan Therapeutics Inc | CGEM | 657,905 | $8.0M | 6.67% |
| 6 | Lyell Immunopharma Inc | LYEL | 8,133,047 | $5.2M | 4.33% |